Over the past century, advances in biotechnology, biochemistry, and pharmacognosy have
spotlighted flavonoids, polyphenolic secondary metabolites that have the ability to modulate …

Parkinson's disease (PD) is primarily characterized by loss of dopaminergic neurons in the
substantia nigra pars compacta region of the brain and accumulation of aggregated forms of …

Neurodegenerative diseases, such as Parkinson's and Alzheimer's, are understood as
occurring through genetic, cellular, and multifactor pathophysiological mechanisms. Several …

Parkinson's disease is characterized by a multifactorial nature that is linked to different
pathways. Among them, the abnormal deposition and accumulation of α-synuclein fibrils is …

Many epidemiological studies have associated coffee consumption with a reduced
Parkinson's disease (PD) risk, but the molecular mechanisms remain unclear. In this study …

In the present decade of accelerated advances in Medical Sciences, most studies fail to lay
focus on ageing diseases. These are diseases that display their symptoms at a much …

Aim: To evaluate the inhibitory interaction of thymohydroquinone against blood–brain barrier
(BBB)-associated neuropsychiatric and neurodegenerative disorders. Materials & methods …

This study aimed to identify specific therapeutic targets for oral squamous cell carcinoma
(OSCC) that metastasize from breast cancer (BC) by using network pharmacology. The …

The main aim of present work is to identification of potency of novel quinoline-4-one
derivatives as a factor Xa inhibitors by in-silico ADME study and molecular docking study …

Neurological disorders such as Alzheimer's Disease (AD), Parkinsons's Disease (PD) and
Cerebral Ischemic Stroke (CIS) are responsible for morbidities in almost a billion people and …